Wyoming Medicaid and GLP-1s

What changed, and what the document says

1. Wegovy needs an event, not a number

   Conditions apply

   Wyoming names the three qualifying histories rather than accepting cardiovascular disease as a category.

   “Client must have BMI of 27 or higher with cardiovascular disease defined as prior myocardial infarction, prior stroke, or peripheral artery disease.”

   Wyoming Medicaid — Last Updated June 8, 2026

2. Zepbound is a sleep-apnea drug here

   Conditions apply

   The criteria open on the diagnosis, and obesity appears only as a qualifier of who gets approved.

   “Client must have diagnosis of moderate to severe obstructive sleep apnea.”

   Wyoming Medicaid — Last Updated June 8, 2026

3. Five percent by six months

   Conditions apply

   The first re-authorization is a weight test, even though the approved indication is a breathing disorder.

   “Prior authorization will be required again at 6 months to show at least 5%”

   Wyoming Medicaid — Last Updated June 8, 2026

4. A second sleep study at twelve months

   Conditions apply

   This is the requirement that sets Wyoming apart. Most states stop at a weight threshold; Wyoming asks for the original test again.

   “Prior authorization will be required again at 12 months to demonstrate improvement in obstructive sleep apnea as evidenced by another”

   Wyoming Medicaid — Last Updated June 8, 2026

5. Metformin before any GLP-1

   Conditions apply

   On the diabetes side Wyoming requires ninety days of metformin in the last year before even a preferred agent, unless cardiovascular disease is present.

   “be required before approval can be given for a preferred agent unless ASCVD or risk factors are”

   Wyoming Medicaid — Preferred Drug List (PDL) June 8, 2026

6. Where the two drugs sit on the list

   Context

   Neither appears in an obesity class, because Wyoming's list does not have one. Wegovy sits under a liver heading and Zepbound under a sleep one.

   “Preferred Drug List (PDL) June 8, 2026”

   Wyoming Medicaid — Preferred Drug List (PDL) June 8, 2026

Which of these companies serve Wyoming?

Of the 387 companies we grade, 34 publish a list of the states they are licensed in. We checked 251 more and found no such list on any page we read; 102 we have not checked either way.

22 of those lists name Wyoming: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon, Peak Wellness, Sprout Health, Allara Health, MEDvidi, and Mixx Health & Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.